Want to see BOLT full AI Analyst Report?
Bolt Biotherapeutics (BOLT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bdc-4182 | Gastroesophageal Adenocarcinoma, Gastric Cancer Adenocarcinoma Metastatic | phase1AndPhase2 | Recruiting | A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer | Apr 04, 2025 | ― |
| Pertuzumab, Bdc-1001 | Metastatic Breast Cancer, Her2-Positive Breast Cancer | Phase II | Terminated | Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer | Jun 23, 2023 | ― |
| Nivolumab, Bdc-1001 | Her2-Positive Breast Cancer, Her2-Positive Solid Tumors, Her2-Positive Colorectal Cancer, Her2-Positive Gastroesophageal Cancer, Her2-Positive Endometrial Cancer | phase1AndPhase2 | Terminated | A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors | Feb 12, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bdc-4182 | phase1AndPhase2 | Gastroesophageal Adenocarcinoma, Gastric Cancer Adenocarcinoma Metastatic | Recruiting | A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer | Apr 04, 2025 | ― |
| Pertuzumab, Bdc-1001 | Phase II | Metastatic Breast Cancer, Her2-Positive Breast Cancer | Terminated | Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer | Jun 23, 2023 | ― |
| Nivolumab, Bdc-1001 | phase1AndPhase2 | Her2-Positive Breast Cancer, Her2-Positive Solid Tumors, Her2-Positive Colorectal Cancer, Her2-Positive Gastroesophageal Cancer, Her2-Positive Endometrial Cancer | Terminated | A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors | Feb 12, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Bolt Biotherapeutics, Inc. (BOLT) have in its pipeline
Bolt Biotherapeutics BOLT is currently developing the following drugs: Bdc-4182, Pertuzumab, Bdc-1001, Nivolumab, Bdc-1001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.